For Clinicians | 2024 First Aid Guidelines

For Clinicians | 2024 First Aid Guidelines

What Changed, and What Your Patients’ Kits Still Get Wrong

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

Your patient bought their first aid kit off an endcap, or from whichever online checklist looked credible. Nobody clinical was standing beside them when they did it. Pharmacists, go look at the kit on your own shelves this week. There’s a good chance it has hydrogen peroxide in it.

Patients tend to assume that buying a first aid kit means they are covered. “Well, it’s better than nothing!” They read a list, buy the box, put it under a truck seat or in a closet, and do not open it again until something goes wrong.

In 2024, the American Heart Association and the American Red Cross published the first comprehensive revision of first aid treatment recommendations since 2010¹. Yet some retail kits still ship to the previous standard and online search results still describe the outdated items.

For a quick real life example, take good ol’ baby aspirin. Many patients still have an 81- mg bottle in the cabinet, and that may be the bottle they’ll grab when a family member’s chest starts hurting. But one 81 mg tablet is below the dose the guidelines recommend in suspected cardiac chest pain. Fixing that takes fifteen seconds in the office or at the counter.

This article covers several changes in the 2024 guidelines, a few common beliefs patients’ kits continue to reinforce, and the larger preparedness gap that first aid guidelines were never designed to fill.

What changed in the 2024 first aid guidelines?

The 2024 document is the first comprehensive revision since 2010, following focused updates in 2015, 2019, and 2020.¹ The writing group identified several new or substantially revised topics: opioid overdose, bleeding control, open chest wounds, spinal motion restriction, hypothermia, frostbite, presyncope, anaphylaxis, snakebite, oxygen administration, and pulse oximetry, with pediatric guidance where it applies.¹ Earlier recommendations remain in effect unless the 2024 document specifically updates them.

Two of those changes reach into the box your patients already own.

Bleeding control: One manufactured windlass tourniquet is now a line item in the Red Cross minimum contents table for a first aid kit.² Not a tactical upgrade. The minimum. But putting one in the kit is only useful if the patient knows when and how to apply it.

Opioid overdose: When a person with a suspected opioid overdose is unresponsive and not breathing normally, the guidelines call for activation of EMS, high-quality CPR with compressions and ventilation, and naloxone.¹ Those actions may overlap. Naloxone is not in the minimum contents table.²

Nobody owns the seam

Those updates reveal a larger problem. Patients do not separate first aid, disaster preparedness, and medication planning. They expect one kit to cover all three. Four quick corrections can make the kit more useful, but they also show where its limits begin.

Two separate bodies of guidance address different parts of the same household emergency plan.

  • On the injury side, the first aid guidelines and Stop the Bleed address immediate care: direct pressure, wound packing, and tourniquet use.³ No mention of prescriptions.
  • On the disaster side, the federal preparedness guidance tells families to keep a written medication list with diagnosis, dosage, frequency, supply needs and allergies, plus a cooler for anything requiring refrigeration.⁴ It says little about how to effectively irrigate a wound or control severe bleeding.

Nobody at home is sorting injury guidance from disaster guidance. There’s one box on hand, and they expect it to cover whatever comes up. 

Patients ask what’s reasonable to keep at home, and neither body of guidance tells you as the provider or pharmacist what’s reasonable to authorize in advance, or where the boundary sits between preparing a patient and writing an inappropriate prescription.

Quick reference: four corrections

Four points cover much of what patients need to know when this subject comes up in the clinic or at the pharmacy counter.

Three involve time-sensitive emergencies in which the right response can save a life. The peroxide correction is less dramatic, but it can prevent avoidable tissue injury and delayed healing.

The layer the kit was never built to hold

This next part is not strictly a first aid question, which is why no first aid guideline answers it.

Some families have the pill bottles and nothing useful for a wound. Others have gauze for days and no plan for the medications they take every morning.

Household medical preparedness has at least three layers. The first is immediate first aid: the supplies and skills used for bleeding, burns, wounds, sprains, and other acute problems. The second is continuity: current chronic prescriptions, an updated medication and allergy list, and a plan for storage or refrigeration.⁴ The third is individualized contingency planning for predictable problems when timely care is unavailable. In selected cases, that may include short-course medication prescribed in advance after a licensed clinician reviews the patient and provides condition-specific instructions.

That third layer is not part of the AHA/Red Cross first aid guidelines. It is a separate clinical decision, and stored medication should be used only under the instructions provided and when qualified medical assistance cannot be reached promptly.

The missing clinical layer

Underneath all four corrections is a structural problem. A household gets one of two things: they reach a clinician, or they work with whatever is in a box assembled to someone else’s checklist. Little formal guidance addresses the space between those options, which is how an endcap product ends up deciding what a family has on hand when something goes wrong.

That clinical layer has a name: individualized medical preparation. It is work completed before an emergency for a limited set of circumstances that may not wait for business hours.A tourniquet and naloxone illustrate the broader principle that useful emergency interventions must often be obtained—and understood—before they are needed. The first aid guidelines do not extend that principle to advance prescribing, but they demonstrate why preparation matters.

This is not a replacement for primary care. Complex diagnoses, ongoing conditions, and clinical uncertainty belong in the exam room. The appropriate role of advance planning is narrower: a defined set of circumstances, a patient screened in advance, clear instructions, and a plan for what requires direct care.

If you’d rather refer

Some of you would rather not write for this at all, which is a reasonable place to land. When a patient asks and you don’t want to be the one deciding what’s appropriate to keep on hand, send them to us at Jase.com. A licensed provider reviews every request and determines if a prescription is appropriate, so the referral is a clinical handoff and not a way around a visit.

We’ll keep publishing where we draw lines, what evidence we’re using, and the criteria behind a no. If we’re going to name a clinical category, the framework should be public enough for other clinicians to scrutinize and argue with.

The bottom line

The guidelines moved in 2024, but many patients’ kits did not move with them. An emergency is the wrong time to discover that the aspirin instructions are incomplete, the tourniquet is missing or unfamiliar, or the only wound cleaner in the box is peroxide.

Tell your patients to spend fifteen minutes with the kit they already own. Check the dates, replace what’s expired, take out what doesn’t belong in a wound, and make sure they know how to use what remains. They may not need a bigger kit. They need a current one and a plan they understand.


Sources

  1.  Hewett Brumberg EK, Douma MJ, Alibertis K, et al; American Heart Association and American Red Cross. 2024 American Heart Association and American Red Cross Guidelines for First Aid. Circulation. 2024;150(24):e519-e579. 
  2. Minimum Contents for American Red Cross First Aid Kit, Table 2, 2024 AHA and American Red Cross Guidelines for First Aid. cpr.heart.org 
  3. Stop the Bleed. American College of Surgeons Committee on Trauma. stopthebleed.org 
  4. Tips for Medication. Ready.gov, Federal Emergency Management Agency.
  5. Wound Home Care. American College of Surgeons. facs.org 
  6. FDA Approves First Over-the-Counter Naloxone Nasal Spray. US Food and Drug Administration, March 29, 2023.

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | Emergency Preparedness in Older Adults

For Clinicians | Emergency Preparedness in Older Adults

The Three Parts That Are Yours

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

Most of your patients over 55 are doing well. Pickleball four mornings a week, a cruise booked for October, a flight out to see the grandkids.

Then something changes the math. A first prescription for blood pressure or thyroid or a statin. A fall that took a lot longer to come back from than it would have at 40. A hospitalization nobody saw coming. Nothing catastrophic, but important enough to stay with them, and afterward a question shows up that never occurred to them at 30: what would I do if I couldn’t get to care?

At 30 nobody asks that. You take nothing, and you have never once considered slipping on your own front steps. By 60 it’s a pertinent question that is top of mind and being discussed at games on the court, on the deck of the ship, and with a whole peer group running the same arithmetic. “What if I can’t get this medication anymore? What if I get hurt again and am far from care?

So they prepare, off the same checklist a 30-year-old would use. She isn’t going to bring that medical preparation to you as her clinician or pharmacist. Three parts of this prep are yours anyway: how long a fill she can get on the prescriptions she already takes, whether the medication reference list in her bag is sufficient, and what she decides to keep on hand for the illnesses that haven’t happened yet.

We’re a team of physicians, PAs, and pharmacists, and we field this question constantly from patients in exactly that age band. Today we’re covering what makes appropriate medical preparation different for this age group than for any other.

Your patients are already preparing, and it’s happening without us

This is not behavior we need to talk anyone into. In a 2019 national poll of adults 50 to 80, 82% said they had a week’s supply of their medications on hand, and 72% had a week of other health supplies.¹ Three-quarters had lived through at least one major emergency in their lifetime. Fewer than a third had actually assembled an emergency kit, and among the patients who depend on electrically powered medical equipment, only one in four had backup power.

So the intent is close to universal and the execution is uneven. The medication half is the part they’ve done best, which makes sense, because it’s the part they already think about every morning.

Then there’s the number that should get our attention. Only 40% had discussed their emergency plans with their own family. If six in ten haven’t raised it with the people they live with, the odds they raised it at their annual visit are worse. The planning is happening, the supplies are being bought, the medication list is being written, and no clinician or pharmacist has looked at any of it.

What makes their preparation different is that it’s mostly a medication problem

For most people under 40, preparation is a supply question. Water, food, a flashlight, a first aid kit, plus some way to hear what’s happening. Medication appears on those checklists, but it isn’t what they’re built around, and for a healthy 30-year-old that doesn’t take any chronic meds it is the right call.

It stops being the right call somewhere in the late fifties. Polypharmacy in adults 65 and older climbed from 23.6% in 1999 to 2000 up to 43.0% by 2017 through March 2020, and the average number of prescriptions per person went from 3.0 to 4.3.² In twenty years, taking five or more prescription medications went from about a quarter of this population to nearly half of it.

So her grandson’s version of this and her’s are not the same exercise. His is bandages, ibuprofen, and a flashlight. Hers is four or five prescriptions she can’t skip for a week, plus everything on his list.

And her four or five medications she does take are not equal, which is the part she may not be able to differentiate on her own. A week without a statin is a non-event. Levothyroxine has enough half-life to forgive a few missed days. A beta blocker stopped abruptly is much more time-sensitive. So are anticoagulants, antiepileptics, and insulin. It’s easy to treat all of them as one undifferentiated pile labeled ‘my medications.’ Sorting that pile into what tolerates a gap and what doesn’t only take 2 minutes and helps flag what is most important to have enough of hand on to prevent a disruption in care.

Part one: how long a fill she can get

Let’s take the easiest of the three first. When a patient asks whether she can get more of a medication she already takes, that’s a dispensing-interval question. Same drug, same dose, same indication, same prescriber. Only the interval changes, and nothing about her pharmacologic exposure does. That is, speaking for general chronic medications. This isn’t the same for controlled substances or acute cases like antibiotics.

So write it long. For a patient who’s worried, you can write a year of refills on a chronic medication up front and let her decide how much to have on hand at any one time. She can pick up a month, or three, or the whole year if her plan allows it. Some plans will cover a full year at once for travel, which is worth asking about rather than assuming.

If you do nothing else with this article, default your chronic prescriptions to 90 days. Your patients end up with a real amount on hand without anyone having to plan for it, and they stop driving to the pharmacy and standing in line twelve times a year for a medication that hasn’t changed in a decade.

Part two: the list in her bag

The AGS tip sheet says to carry a written medication list that contains all brand and generic names and doses a patient takes regularly.³ That’s the right instruction, and it’s the one she’s most likely to have done badly, because most people don’t have this written down and just cite it from memory. What comes out is “the little white one for blood pressure” and a dose she’s half sure about. And to make matters more complicated many patients pharmacy shop for the best price on medications so the Rx are spread across pharmacy chains and multiple prescribers with no central EMR hub all healthcare professionals can access.

A clearly printed, and accurately updated med list is usable by a pharmacist who has never met her. Drug, strength, and directions for each item, and the condition each one treats. Indication is important to remember and not leave off either. Add her allergies, adverse reactions to previous medications, and your office phone number while you’re at it.

This simple list costs almost nothing. Your MA can print the med list at check-out in a minute. Just make sure to add the medications prescribed by other HCPs she sees. Better than that, have her ask her pharmacy(ies) for a printed profile, because the dispensing record shows what she has actually been filling and when, which is often closer to the truth than what’s in the chart. Reconciling those two against each other is the whole exercise that is most helpful. If they disagree, you and she have learned something worth knowing whether or not a disaster ever shows up.

Part three: what she keeps on hand for what hasn’t happened yet

This is the part that earns the skepticism, and it’s also the part where the answer moves with the decade. A healthy 58-year-old on one antihypertensive is not a Beers patient⁴. A 78-year-old on four medications, with a creatinine clearance you’d want in front of you first, is a different conversation. The difference isn’t age by itself. It’s the list she’s already on.

A single new drug isn’t generally a big deal.  It’s when another is added to a polypharmacy list that there’s more for it to bump into for drug-drug interactions and drug-condition interactions. And the kidneys are slower, so the same dose hits harder. The 2023 Beers criteria are still current as of this summer if you want the reference.

And, since we are talking about appropriate medical preparation, if she’s in a situation where she can’t reach a healthcare professional she’s the one who decides whether to take it with nobody to ask. The bottle won’t tell her when not to. You will, ahead of time, while she’s feeling fine. Anything she keeps on hand is for an emergency, after she’s tried to reach a provider, and she only knows that because somebody told her. That’s the argument for having the conversation about how to prep well instead of saying no and sending her to figure it out herself with the internet chat rooms as guide.

The drug-by-drug version of what medications are appropriate for seniors in emergency kits is its own article and we’re writing it: what to look for in medical preparation after 70, and which contents actually matter at that age. 

The missing middle layer

Here’s the structural problem underneath all three parts. Care in this country is all or none. Either she reaches a clinician and gets a prescription, or she’s on her own with whatever happens to be in the house. Nothing sanctioned sits in between, which is how a reasonable 64-year-old asking a reasonable question ends up choosing between a no from her prescriber and whatever she finds on her own.

Appropriate medical preparation is the name for that middle layer. One bounded step, taken ahead of time, by a clinician, for the disruptions that actually happen to people her age: the week she can’t get to the pharmacy, the storm, the trip that puts her four hours from a clinic. Or international travel.

It isn’t a replacement for the clinician or the pharmacist she already has. It doesn’t manage her chronic conditions, it doesn’t follow her labs, and it makes no decision at the point of use. It’s what’s on the shelf for the times you aren’t reachable, used in an emergency, after she’s tried to reach someone.

If a patient in that age band asks and you’d rather not be the one to build an appropriate medication kit with her, you can send her to us at Jase.com. A licensed provider reviews every request and writes every prescription, so it’s a handoff rather than a workaround.

We’ll keep publishing where we draw the lines, including the lines that run through our own products. Right now that conversation is happening on the pickleball court with nobody clinical in it. That’s the part we’re trying to fix.


Sources

  1. National Poll on Healthy Aging. Emergency Planning among Older Adults. University of Michigan Institute for Healthcare Policy and Innovation, with support from AARP and Michigan Medicine. Fielded May 2019, published September 4, 2019. n = 2,249 adults ages 50 to 80. https://www.healthyagingpoll.org/reports-more/report/emergency-planning-among-older-adults
  2. Innes GK, Ogden CL, Crentsil V, Concato J, Fakhouri TH. Prescription Medication Use Among Older Adults in the US. JAMA Internal Medicine. 2024;184(9). NHANES, January 1999 through March 2020, 14,917 adults aged 65 and older. Polypharmacy, defined as 5 or more prescription medications, rose from 23.6% to 43.0%; mean medications per person rose from 3.0 to 4.3. https://jamanetwork.com/journals/jamainternalmedicine/article-abstract/2820722
  3. American Geriatrics Society. Tip Sheet: Emergency Preparedness for Older Adults. HealthInAging.org, September 2019. https://www.healthinaging.org/tools-and-tips/tip-sheet-emergency-preparedness-older-adults
  4. By the 2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society. 2023;71(7):2052-2081. doi:10.1111/jgs.18372. https://pubmed.ncbi.nlm.nih.gov/37139824/

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | Emergency Prescription Refills and 90-Day Fills

For Clinicians | Antibiotic Eye Drops for Pink Eye

What to Do When a Patient’s Pharmacy Is Closed

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

“I’m from out of town and I just took my last pill from another pharmacy. Can you give me a refill? I reaaaaally need this med”

I’ve had this happen to me dozens of times every ski season in the mountain town pharmacy I worked at for years. Friday at 4:50pm when all offices are closing up shop for the weekend. People don’t always have the pharmacy closest to them open and ready with their prescriptions. It happens for all sorts of reasons.  A hurricane or a holiday weekend. A staffing shortage that closed the pharmacy early with no sign on the door guaranteeing when they will open again. A power outage. Or the chain closed a batch of locations in one fell swoop when they went under.

Today we’re talking about closed pharmacies, and about how much of this is preventable from our side of the encounter. First, what you can put in place ahead of time so a closed pharmacy is an inconvenience instead of a crisis. Second, what you and your patient can do once the door is already locked and Monday is three days away.

How much medication do your patients actually have on hand?

Here’s how I think about this as a pharmacist. Picture a patient on a 30-day prescription. Their plan lets them refill once they’ve used about 75 percent of it, so somewhere around day 22. Most people go pick it up right then, because that’s when the pharmacy texts them that it’s ready. So they walk out with 30 new pills while a week of the old bottle is still sitting at home. Seven or eight pills, if it’s a once-a-day medication.

That’s the whole cushion. Seven pills. Nobody chose that number. It falls out of a 30-day fill and a refill window, and that’s the only reason it’s seven. If you’re prescribing rather than dispensing, this is the part you never see, because the refill math happens weeks after the patient leaves your office.

Now here’s what bugs me. Nobody agrees on the number. The Red Cross says keep a 7-day supply of medications.¹ The CDC’s own emergency kit checklist says at least two weeks.² FEMA’s Build a Kit page lists prescription medications and never names a number at all.³ Seven days is the one that propagated out to every state and county checklist, and seven days is what the patient already had by accident. The one study I know of that looked at what a household actually needs put the number at 14 to 30 days, and said the way to get there is longer fills.⁴ The CDC is closest to right and nobody is following it.

What to put in place ahead of time

These are workflow changes, not clinical ones. 

  • Default to a 90-day fill on stable chronic medications. Same drug, same dose, same annual quantity. What changes is how often that patient has to stand in a line for it.
  • Synchronize the refill dates. A patient on five chronic medications with five different fill dates is making five trips a month and getting five separate chances to run out on the wrong weekend. Write them all in one visit, aligned to a single date. The AAFP has recommended this for years as practice management, and it’s the same action with a different reason attached.5 Your MA can call the pharmacy to align the first cycle so it doesn’t eat your afternoon.
  • A year is on the table, and most people don’t know it. For chronic medications that aren’t controlled substances, a prescriber can authorize up to a year of a patient’s own validated prescription to fill at a single time. Plenty of prescribers assume that isn’t allowed. Insurance likely will only cover 90 days regardless of what you wrote. It’s something for the patient to ask about, not something to promise them.
  • Put the list on paper. Every medication in the house, with drug, dose, prescriber, and pharmacy. A pharmacist who has never met your patient can work from that list. Without it we’re guessing, and we don’t fill on a guess. Simple solution is to just print their med list from your EMR and give it to the patient instead of having the MA re-write everything by hand.

Can another pharmacy fill your patient’s prescription?

Usually yes, and more easily than most patients expect. Inside a chain, any store can pull up that patient’s prescriptions and fill them. Controlled substances get more complicated, but even then the new store can see the prescription and who wrote it, which is enough to start the conversation.

Outside the chain, it comes down to whether the patient brings the bottle. When someone handed me their bottle from another pharmacy, I could verify the prescription off the label, get them an emergency supply, and call their office Monday for a formal script. Without the bottle, at 8:55 on a Sunday night, there was nothing I could do for them because I couldn’t just take their word for it that they were taking that specific Rx.

So the counseling is four things:

  • Bring the bottle to the pharmacy where you are. The label is what makes verification possible.
  • Call ahead instead of walking in. Five minutes before close is the worst possible time to ask.
  • Give lead time. “I have three pills left” on Thursday morning opens doors that “I’m out” on Friday at 5:59pm does not.
  • Expect to pay cash. Insurance usually won’t process a fill this way, and a patient shouldn’t expect coverage. Great time for a discount card.

Two extra things to know. The first is the 72-hour emergency supply. A pharmacist’s authority to dispense without prescriber authorization varies enormously by state, and a meaningful number of states give pharmacists none at all. Several states that do have public-health-emergency provisions require a governor’s declaration to activate them, so the advice is weakest in the situation patients actually find themselves in: an ordinary Friday, nothing declared, nothing activated. Look up your own state before you tell a patient to count on it.6 It’s really more for epic natural disaster situations.

The second is Schedule II. There is no refill mechanism under federal law, so a patient who runs out on the road needs a new written prescription, not an authorization. A prescriber can verbally authorize an emergency quantity limited to the emergency period, with the written prescription delivered to the pharmacy within days. This is federal, so a state’s emergency dispensing rules don’t create a workaround. For patients on stimulants or opioids, that’s a conversation to have before the trip, not during it.7

Ahead of time there is one thing you can do. Federal rules let you issue multiple Schedule II prescriptions totaling up to a 90-day supply, each one marked with the earliest date a pharmacy may fill it, where your state permits it and where you judge there’s no undue diversion risk.⁷ It isn’t a refill and the regulation is careful to say it isn’t an expectation, but it’s the closest thing these patients have to the 90-day fill everyone else gets.

Everything above is a workaround

Now that we’ve covered the basics, look at what this article has covered. A longer fill, because the default one is too short. A bottle carried to a stranger’s counter, because there’s no other way to verify. A 72-hour supply that depends on which state line your patient happens to be standing behind. Every one of these gets around the same absence. There’s no sanctioned step between reaching a clinician and being on your own with whatever is in the cabinet. Care is all or none. Either your patient gets to someone who can write or verify, or they’re counting seven pills on a Friday night.

That missing step is what we build at Jase, and the category has a name: appropriate medical preparation. For a short list of well-understood conditions, the clinical work happens on the front end. A licensed provider reviews the request and writes the prescription before anything ships, so the patient isn’t hunting for a prescriber at 8:55 on a Sunday night. It’s for emergency use only, after first seeking the assistance of a qualified healthcare provider.

This is in no way a replacement for primary care. Chronic disease management, complex diagnoses, and the ongoing relationship belong with you. What a JaseCase holds is the acute layer a disruption creates, the infection or injury that shows up during the week nobody can reach a pharmacy. The chronic half of the problem is the one you solve, in your office, with the four things in the list above.

If you’d rather refer

Some of you will want to work out the day-supply and standby-prescribing questions yourselves, and you should. Some of you have a full panel and no room for a new category of conversation inside a 15-minute visit or a line at the counter. Either is a reasonable place to land. If it’s the second, send them to us at Jase.com, where one of our licensed providers reviews the request and writes anything prescription that gets filled.

The criteria are the part we owe you. Which conditions qualify, what we decline to prescribe ahead of time and why, and how we handle the cases that don’t fit cleanly. We publish that here as we settle it, so you can argue with it or borrow it.

TL;DR

Patient calls, their pharmacy is closed:

  • Same chain nearby? Any store can pull their profile and fill it.
  • Different pharmacy? Bottle in hand, call ahead, expect cash.
  • Schedule II? No refill exists. New written prescription, or a verbal emergency quantity with the written script following in a few days.
  • No bottle and nobody reachable? A state emergency supply, if your state has one.

Every workaround in this article exists because there’s no sanctioned step between reaching a clinician and going without. We’re building that step and publishing the criteria as we set them. Until it exists, the shortest path runs through the script you write: ninety days instead of thirty, synced to one date, printed on a list your patient can hand to a stranger.


Sources

  1. American Red Cross. Survival Kit Supplies. “Medications (7-day supply) and medical items.” https://www.redcross.org/get-help/how-to-prepare-for-emergencies/survival-kit-supplies.html 
  2. CDC. Emergency Kit Checklist: Pregnant Women, Infants, and Children. Updated April 30, 2026. “Prescription medications (at least 2 weeks supply).” https://www.cdc.gov/children-and-school-preparedness/resources/emergency-kit-checklist-pregnant-women-infants-and-children.html 
  3. FEMA. Build A Kit, Ready.gov. Updated July 1, 2026. Lists prescription medications among additional emergency supplies with no day-supply figure given. https://www.ready.gov/kit 
  4. Carameli KA, Eisenman DP, Blevins J, d’Angona B, Glik DC. Planning for chronic disease medications in disaster: perspectives from patients, physicians, pharmacists, and insurers. Disaster Medicine and Public Health Preparedness. 2013;7(3):257-265. Los Angeles County sample. “Most prescriptions are dispensed as 30-day units through retail pharmacies with refills available after 75% of use, leaving a monthly medication reserve of 7 days.” Health professionals in the study supported 60- to 100-day dispensing units to reach the recommended 14- to 30-day reserves. https://pubmed.ncbi.nlm.nih.gov/23103395/ 
  5. Sinsky TA, Sinsky CA. A Streamlined Approach to Prescription Management. Family Practice Management. 2012;19(6):11-15. The physician renews all of a patient’s chronic medications, excluding narcotics and benzodiazepines, at the annual comprehensive care visit; estimated saving of one to two hours of physician and staff time daily. https://www.aafp.org/pubs/fpm/issues/2012/1100/p11.html 
  6. Healthcare Ready. A Review of State Emergency Prescription Protocols. September 18, 2022. 16 of 51 jurisdictions have no laws or regulations pertaining to emergency prescriptions; 23 allow a general emergency refill; 12 have public-health-emergency-specific provisions, of which 10 activate on a governor’s declaration. More than half of states allow only a 72-hour emergency supply or none at all. https://healthcareready.org/a-review-of-state-emergency-prescription-protocols/ 
  7. 21 CFR 1306.12(a): “The refilling of a prescription for a controlled substance listed in Schedule II is prohibited.” 21 CFR 1306.12(b): a practitioner may issue multiple Schedule II prescriptions totaling up to a 90-day supply with earliest-fill dates marked, where permissible under state law. 21 CFR 1306.11(d): an emergency oral Schedule II prescription is limited to the quantity needed for the emergency period, and the prescriber must cause a written prescription to be delivered to the dispensing pharmacist within 7 days. https://www.ecfr.gov/current/title-21/part-1306

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | Antibiotic Eye Drops for Pink Eye

For Clinicians | Antibiotic Eye Drops for Pink Eye

What the Evidence Says and What Schools Still Require

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

But the school won’t take him back without the drops. I need them!

That sentence gets said at pharmacy counters and repeated into phone triage every week by the frantic parents of kids with pink eye. A kid woke up with one lid crusted shut, the front office called by 9:15, and now a parent is standing in front of one of us needing an Rx so their child can go back to school or daycare.

So we write the script. Yep. About 69% of the time, going by the claims data.¹

Today we’re talking about what those antibiotic eye drops actually do. Then why the visit is usually about authorization rather than infection, the one presentation where antibiotics make a difference (it isn’t drops), and the short list of findings that should change the plan no matter what the school form says. Let’s jump into what to do about those goopy eyes that look awful.

Do antibiotic eye drops change the course of pink eye?

A little, in the cases that are actually bacterial, and not nearly enough to explain how often we reach for them.

The 2023 Cochrane review pooled 21 trials and 8,805 patients with acute bacterial conjunctivitis. About 55% of the placebo group cleared on their own by day four to nine, compared with 68% on antibiotics.² That works out to a number needed to treat of 7 for clinical cure, against a number needed to harm of 32 for ocular adverse effects with the non-fluoroquinolone drops.³ By day six to ten the two groups have mostly converged.

That is the ceiling on the benefit. It only applies to the bacterial cases. The problem here is that we cannot reliably tell which ones those are. AAFP’s 2024 clinical review states that no single sign or symptom accurately differentiates viral from bacterial conjunctivitis,⁴ and that includes the two findings most of us rely on, purulent discharge and morning matting. So the drops go out to a mixed population in which we cannot cleanly identify the patients who stand to benefit.

The prescribing data shows how that plays out. Across 44,793 pediatric ambulatory encounters, topical antibiotics were dispensed within a day for 72% of office-based visits and 57% of ED visits, but only 34% of eye clinic visits.¹ You could reasonably say that is specialty selection, since eye clinics see referrals rather than the 9:15 phone call. Fair enough. Then look at the encounters where viral conjunctivitis was the documented diagnosis, where there is nothing for an antibiotic to act on: 28% of those children got drops anyway.¹

The 24-hour rule is school policy, not a clinical standard

Nothing in pediatric guidance requires a child with pink eye to be on drops before going back to school or daycare. The AAP position, carried in the Red Book and in Managing Infectious Diseases in Child Care and Schools, is that a child with conjunctivitis and no fever and no change in behavior does not need to be excluded, and that otherwise healthy, well-appearing children with red, watery eyes should not be excluded or isolated at all.⁵ 

Now let’s check out what states actually publish. A 2022 survey of all 50 state policies found:

  • 15 states have no conjunctivitis policy at all
  • 10 allow students to stay in school
  • 5 permit return 24 hours after starting antibiotics
  • 5 require a physician’s approval
  • 17 states plus DC give inconsistent recommendations, and not one state policy anywhere references the American Academy of Ophthalmology⁶

So the 24-hour rule that sends these families to us is written into state policy in five states.

Before we make the school nurse the villain, though: they are working from guidance that does not agree with itself. AAO’s own patient education page, updated August 2024, advises staying home until symptoms start to improve.⁷ AAP says don’t exclude. A district with no state guidance to point to picks the rule that sounds careful, and 24-hours-on-antibiotics is the one everybody has heard and feels better for parents who don’t want their kids to catch the goop eye from other kids in the class.

This is what gets awkward and that we weren’t really trained for. We were taught to make a clinical decision about an infection. What we are being asked for is authorization to re-enter a building, and it costs the family a visit and a copay to get it.

The drops are not buying a smoother course either. In that same pediatric cohort, ambulatory revisits within 14 days ran 3.1% among children who got antibiotics and 3.6% among those who did not, hospitalizations 0.03%, ED revisits 0.12%, with no differences between the groups.¹

Check out what your own state actually publishes before you write the Rx. In 15 of them, there is nothing to comply with.

Check the ears when you see the eye

There is one presentation where antibiotics clearly do the work, and the treatment is oral, not topical.

Conjunctivitis-otitis syndrome is a good one to remember in the back of your mind. Ear infections turn up alongside bacterial pink eye often. Published estimates run from 32% to 73%, and plenty of those kids never complain about ear pain.9 Haemophilus influenzae is the usual culprit. It was 70% of isolates in a cohort of 67 children with conjunctivitis plus a concurrent ear or sinus infection.⁸ Drops cannot reach the middle ear, so they do not fix the real problem. Close to 30% of US Haemophilus influenzae isolates resist ampicillin, and amoxicillin fails the same way, since the resistance is usually a beta-lactamase.¹⁰ Amox-clav holds up against almost all of them. So amox-clav or cefdinir here, not plain amoxicillin.

Look in the ears of every kid whose parent brings you a red, crusted eye, including the ones with no ear symptoms. If the ear is involved, you treat one infection with one oral antibiotic and the eye clears with it. That is the case where the right answer is an Rx, and it still isn’t drops.

What actually changes the plan

Short list, and none of it depends on sorting viral from bacterial (which is the point, since we cannot do that reliably anyway).

  • Contact lenses. Any lens wearer with a red eye gets seen today, not tomorrow. Contact-lens-associated keratitis is most often Pseudomonas, and it can leave permanent central corneal scarring and vision loss even when treatment is prompt and appropriate.¹¹ ¹² Empiric coverage needs a fluoroquinolone, and these patients belong with ophthalmology.
  • Moderate to severe pain, any change in vision, or photophobia. Not conjunctivitis territory anymore.¹¹
  • Sudden heavy purulent discharge in a sexually active adolescent or adult. Treat as gonococcal until proven otherwise. It needs systemic ceftriaxone with empiric anti-chlamydial coverage and same-day ophthalmology, because untreated it progresses to corneal melting and perforation.¹³
  • A baby under a month old.  Different illness, and it needs a clinician today rather than drops.⁷
  • Not improving, or keeps coming back. Failure to respond and recurrent episodes both go to ophthalmology.¹¹
  • Anything you find yourself wanting a steroid for. Steroids can slow corneal healing and raise intraocular pressure, and ‘needs steroids’ is itself a referral criterion.¹¹

The contact lens question is the one to build into intake. Your MA or tech can ask it before you ever walk in the room. It is most likely to get missed on a busy afternoon.

All other treatment is a warm cloth, hand hygiene, and a few days to pass.

Where preparation actually helps here

Look again at what the parent in the opener was offered. Two options: get an Rx, or keep the kid home. Nobody handed them the third thing, which was a plain statement of what their state and their district actually require and if the drops actually help the condition. That’s similar to most access problems we write about. Care is either fully authorized or fully unavailable, with nothing sanctioned in between. Usually the missing middle is a medication that should have been on the shelf before anyone needed it. Appropriate medical preparation means having the right thing ready before you need it, and sometimes the right thing turns out to be a warm cloth, four days, and knowing you are not cutting a corner.

The bottom line

Most pink eye clears on its own. Antibiotic drops help modestly in the cases that are bacterial, and we cannot reliably tell which ones those are. The 24-hour rule that sends these families to us is school policy, not medicine, and in most states nobody wrote it down at all.

Look in the ears, and know the short list that changes the plan. The rest is a conversation, and that conversation is worth more to the family than the prescription is, even if they really want that Rx when they walk in the door to see you.


Sources

  1. Shapiro DJ, Geanacopoulos AT, Subramanian SV, et al. Antibiotic Treatment and Health Care Use in Children and Adolescents With Conjunctivitis. JAMA Ophthalmology. 2024;142(8):779-780. https://jamanetwork.com/journals/jamaophthalmology/fullarticle/2820326
  2. Chen YY, Liu SH, Nurmatov U, et al. Antibiotics versus placebo for acute bacterial conjunctivitis. Cochrane Database of Systematic Reviews. 2023;3:CD001211. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001211.pub4/full
  3. Sonoda K, Takeuchi Y. Antibiotics for acute bacterial conjunctivitis. American Family Physician. 2023;107(6):581A-581B. https://www.aafp.org/pubs/afp/issues/2023/0600/mbtn-acute-bacterial-conjunctivitis.html
  4. Winters S, Frazier W, Winters J. Conjunctivitis: Diagnosis and Management. American Family Physician. 2024;110(2):134-144. https://www.aafp.org/pubs/afp/issues/2024/0800/conjunctivitis.html
  5. Children’s Mercy Kansas City. Conjunctivitis Care Process Model: Recommendations for Inclusion or Exclusion from Daycare/School, citing the AAP Red Book (2015) and the 2002 AAP / American Public Health Association child care exclusion recommendations. https://www.childrensmercy.org/health-care-providers/evidence-based-practice/cpgs-cpms-and-eras-pathways/conjunctivitis-care-process-model/recommendations-for-inclusion-or-exclusion-from-daycare-school/
  6. Lee T, Kuo IC. Survey of state conjunctivitis policies for school-age students. Journal of AAPOS. 2022;26(3):115.e1-115.e5. https://pubmed.ncbi.nlm.nih.gov/35378302/
  7. Mukamal R. When Do You Need Antibiotics for Pink Eye (Conjunctivitis)? American Academy of Ophthalmology, reviewed by Rupa K. Wong, MD, August 26, 2024. https://www.aao.org/eye-health/tips-prevention/over-prescription-antibiotics-pink-eye
  8. Hu YL, Lee PI, Hsueh PR, et al. Predominant role of Haemophilus influenzae in the association of conjunctivitis, acute otitis media and acute bacterial paranasal sinusitis in children. Scientific Reports. 2021;11. https://pmc.ncbi.nlm.nih.gov/articles/PMC7794412/
  9. Conjunctivitis and Conjunctivitis-Otitis Syndrome. Pediatric EM Morsels. https://pedemmorsels.com/conjunctivitis-and-conjunctivitis-otitis-syndrome/
  10. Potts CC, Rodriguez-Rivera LD, Retchless AC, et al. Antimicrobial Susceptibility Survey of Invasive Haemophilus influenzae in the United States in 2016. Microbiology Spectrum. 2022;10(3):e02579-21. https://pmc.ncbi.nlm.nih.gov/articles/PMC9241922/
  11. Hashmi MF, Gurnani B, Benson S. Conjunctivitis. StatPearls. Updated January 26, 2024. https://www.ncbi.nlm.nih.gov/books/NBK541034/
  12. Hatami H, Ghaffari Jolfayi A, Ebrahimi A, et al. Contact Lens Associated Bacterial Keratitis: Common Organisms, Antibiotic Therapy, and Global Resistance Trends: A Systematic Review. Frontiers in Ophthalmology. 2021;1:759271. https://www.frontiersin.org/journals/ophthalmology/articles/10.3389/fopht.2021.759271/full
  13. Dvorak SF, Lee C. Hyperacute Gonococcal Conjunctivitis. Brown Hospital Medicine. 2025;4(4). https://bhm.scholasticahq.com/article/144966-hyperacute-gonococcal-conjunctivitis

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | The September Asthma Epidemic

For Clinicians | The September Asthma Epidemic

Why the Controller Refill Matters More Than the Rescue Inhaler

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

Right now your patients are buying pencils, brand new white sneakers that’ll stay white for only a few days, a graphing calculator they’ll use twice, and a backpack with so much storage space. They’re paying registration fees and signing a stack of forms about photo permissions and field trips. Very few of them are making a back-to-school doctor’s appointment, and almost none of them are thinking about the inhaler that has been sitting in a drawer since late May.

Asthma doesn’t make the back-to-school list. For most of these kids, the next time they cross our radar is the third week of September, when a refill request hits the pharmacy, a parent calls the office at 7am, or the exacerbation lands in the ED.

This season is the most predictable respiratory event of the school year, and the medication that blunts it has to be restarted before the first bell. Not after the first bad night strikes.

So this is the time to dust off the inhalers. Today we’re talking about the September asthma epidemic: why hospitalizations spike two to three weeks after school starts, why the controller is the inhaler that matters here and the rescue inhaler isn’t, and what has to be signed before the surge instead of during it.

Why does childhood asthma get worse in September?

Because three separate things arrive in the same two weeks. A rhinovirus moves through a building full of kids who haven’t shared air since May. Ragweed peaks in September and mold counts climb as leaves come down. And controller inhaler use is sitting at its annual low.1,2

The size of it is bigger than you’re probably mentally calculating it is as well. In Canadian surveillance, 20% to 25% of all childhood asthma exacerbations requiring hospitalization occurred in September.¹ In school-age children the peak lands on average 17.7 days after Labor Day. Preschoolers peak at 19.4 days, and adults at 24.¹ The surge starts in the classroom and affects everyone else in the family in a domino effect after that.

You’re reading this thinking it’s just fall, and asthma is worse in fall. That was the assumption for years. Yet, it’s the school calendar that actually broke it. Scotland and Sweden send kids back in the third week of August, and that is when their peaks land. England and Canada go back the first week of September, and theirs land then.¹ Large peaks show up two to three weeks after school return in all four countries, with Scotland’s and Sweden’s smaller in amplitude.¹ Move the return date, move the peak. The epidemic has been documented in the US, the UK, Mexico, Israel, Finland, Trinidad, and Canada.1

Viral infection, mostly rhinovirus, is associated with roughly 80% of asthma exacerbations in this age group.¹ Which matters, because the medication that lowers exacerbation risk in that setting is the most important one. Prescription data show fewer asthma medication fills over the summer months, especially for children, and inhaled corticosteroid adherence is poor at baseline and likely worse in summer.¹

Controller or rescue inhaler: which one prevents the September spike?

The controller. The rescue inhaler treats an attack that has already started. The controller is what makes that attack less likely when a rhinovirus comes through the classroom. Nearly every back-to-school checklist tells parents to make sure there’s a rescue inhaler at school. That advice is correct. Yet, it’s still the wrong thing to lead with, because a rescue inhaler is what you reach for after prevention has already failed.

Current GINA guidance is pretty blunt: a short-acting beta agonist should not be used alone at any step.³ For adults and adolescents the preferred track is as-needed ICS-formoterol, which cuts severe exacerbations by roughly 60% compared with a SABA-only reliever.³ For children 6 to 11 with mild persistent asthma it’s daily low-dose ICS with as-needed SABA, and at the mildest step, ICS whenever the SABA is taken.³ So a child whose only asthma medication is albuterol is undertreated by current guidance. A child who has a controller prescription and stopped filling it in May is in the same position.

A lapsed controller medication doesn’t announce itself, either. The kid feels fine in July, which is partly what a working controller is for, and can feel superfluous so it gets dropped. There’s no symptom to report, no visit to schedule, and nothing in the chart to look at. Asthma that has been well controlled all summer can look and feel identical to asthma nobody has treated since May.

One place that this is visible is through a pharmacist’s eyes checking out their Rx fill history. A last 30-day ICS fill in April with three refills untouched is a big flag that asthma for this child is likely uncontrolled. The pharmacy for most of these families is the only place a clinician touches them before September. An albuterol refill request in August is worth two minutes of fill-history review, and a technician can pull it before the counseling conversation ever reaches you.

What has to be signed before the first bell

Almost no parents are scheduling back-to-school visits for their kids with you. So all the work is done with parent phone calls or pharmacy requests.

Three documents to know about to be able to refer patients to:

  1. The self-carry authorization. All 50 states have laws letting a student carry and self-administer their own inhaler at school.⁴ The laws vary, and many districts still require written parent and prescriber permission on file, often renewed each year. Last year’s form doesn’t always carry over so double check that. 
  2. The asthma action plan. Clinician-completed, listing medications, triggers, and the step-by-step response. Schools want a current one.
  3. The medication the school keeps. Where district policy requires a supply in the health office, that’s a second labeled inhaler and a second prescription.

A national analysis of these state policies found enough gray area in how they’re written that schools misinterpret them, and children end up without immediate access to an inhaler they are legally entitled to carry.⁵ 

One more thing that stalls August refills: albuterol shortage headlines. The current shortage is nebulizer solution, not the metered-dose inhaler most of these kids carry. But it is a good reminder that drug shortages happen frequently and it is a very good idea to have the medication you need already on the shelf, instead of hoping you can get it in an emergency.

Preparation is the whole point

School inverts the way parents can help kids during a health event. A kid in a classroom, or a student three states away at college, handles the first ten minutes alone with whatever is in the backpack or the dorm room. That’s what appropriate medical preparation means in practice: the clinical decisions made ahead of time, so nobody is improvising during the emergency.

For September asthma the thing that has to be in hand in August is the controller medication, and that comes from your office and your pharmacy. Jase carries albuterol and epinephrine auto-injectors as JaseCase add-ons, which covers the emergency layer rather than the daily one. That complements what you’re already doing. We’re here for the times you aren’t reachable.

The bottom line

The September asthma peak is already on the calendar for 2026 in your area. It’ll hit two to three weeks after the first school bell rings. The medication that changes the outcome is the controller nobody has filled (or thought of) since spring. That gets fixed in August by you, over the phone or at the counter. A fill-history check and a signed form now are cheaper than an ED visit in six weeks.


Sources

  1. Sears MR, Johnston NW. Understanding the September asthma epidemic. J Allergy Clin Immunol. 2007;120(3):526-529. The 20% to 25% September share is Canadian surveillance data.
  2. Asthma and Allergy Foundation of America. The September asthma epidemic. community.aafa.org/blog/september-asthma-epidemic
  3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025 update. ginasthma.org
  4. Allergy & Asthma Network. State laws on student self-carry and self-administration. advocacy.allergyasthmanetwork.org/state-laws
  5. National Analysis of State Health Policies on Students’ Right to Self-Carry and Self-Administer Asthma Inhalers at School. Journal of School Health. 2018.

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!

For Clinicians | MenACWY vs MenB

For Clinicians | MenACWY vs MenB

A Back-to-School Meningococcal Vaccine Refresher

By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, Jase
Medically reviewed and edited by Kristen Carpenter, PA-C

Fall is coming, and with that are newly minted college students heading off to live in the dorms. That means meningitis is particularly top of mind. While the disease itself isn’t seasonal, the vaccines feel like they are because this is the moment when parents and students consider them more than ever as many college forms require action with the vaccine. To add to the confusion, there are two separate vaccines, plus combination products. MenACWY is routine and MenB isn’t, exactly. And the two pentavalent products that cover both can’t be swapped for each other partway through a series.

Parents ask whether the shot their kid got at 11 still counts, and a fair number of us have to look it up before we answer. I know I do! The meningococcal schedule has been revised more than once since most of us trained, and the version we memorized had fewer moving parts.

So this is a refresher on meningitis vaccines for you: what’s routine, which products follow which, and what these vaccines don’t cover.

Which one does the college form actually require?

MenACWY, almost always.

CDC recommends MenACWY routinely for every adolescent, first dose at 11 to 12 and a booster at 16.¹ That’s what most state college-entry requirements are built around, and most of those apply to students living in on-campus housing rather than to everyone enrolled. The rules vary by state and they get revised, so check the state your student is moving to, not the one they’re leaving.

So when a family tells you “she already got the meningitis shot,” they almost always mean MenACWY, and they’re usually right that the form is handled. 

MenB is an option, not a default

So a parent will inevitably ask you in the next few weeks: “Does she need MenB too? What even is that?”

MenACWY covers four of the five serogroups that cause most disease. MenB covers the fifth. For a healthy teenager, MenB isn’t automatic. This bug gets killed by one particular part of the immune system, so when that part is missing, broken, or switched off by a medication, catching it is a much bigger deal. That’s kids without a working spleen, kids born with a gap in that defense, and anyone on eculizumab or a drug like it, which raises the risk roughly 2,000-fold.² Lab workers who handle the bacteria and anyone caught in a B outbreak, too.² All of them get MenB.

So why isn’t it routine for everyone else? Incidence is very low, and MenB gives what ACIP itself calls short-term protection.² Rare disease plus short-lived protection is a hard case for universal vaccination. Against that, serogroup B caused every US college outbreak from 2011 to 2019.³ Both of those are true at once, which is how this became a conversation instead of a rule. You and the family decide together if this vaccine is right, and ACIP calls that shared clinical decision-making.

Vaccine Schedules

This is the part that trips people up, and it’s the easiest one to miss on a records review.

There are two combination shots that cover all five serogroups in one injection: Penbraya from Pfizer and Penmenvy from GSK. 

  • The MenB half has to match all the way through. Penbraya carries Pfizer’s MenB antigen, so the second MenB dose is Trumenba. Penmenvy carries GSK’s, so the second dose is Bexsero.⁴
  • The two combination shots aren’t interchangeable with each other. Don’t start with one and finish with the other.⁴
  • A combination shot is for the visit where the student is due for MenACWY and has already decided on MenB. It doesn’t replace the routine MenACWY schedule on its own.⁴
  • MenB is two doses, 0 and 6 months, for healthy 16 to 23 year olds.² Start at 16 and the series is finished well before move-in.

So when a student turns up with a partial series, the question is which brand, not just which vaccine. If the record says “MenB” and nothing else, get the product name before you give dose two.

Why neither the shot record nor the rash rules bacterial meningitis out

Meningitis isn’t one disease. It’s inflammation of the meninges, and the causes run from enteroviruses to pneumococcus to Haemophilus influenzae type b to the occasional fungus. The shots we’ve been talking about cover exactly one of those organisms, and MenACWY covers only four of its five serogroups. “Meningitis vaccine” is a shorthand that promises a lot more than the vial delivers.

That chasm is where two kinds of false reassurance come from: the vaccine record and the rash. Neither one rules anything out.

First:she’s vaccinated, so it can’t be meningitis.” MenACWY doesn’t cover B. No meningococcal vaccine covers pneumococcus, Hib, or any virus. And viral meningitis is the most common kind, usually self-limiting, with most people better in a week to ten days.⁵ Odds are good that what walks in to the clinic isn’t meningococcal. That’s the reassuring part, and it’s also why the shot record can’t rule anything out.

Second: the rash. In Thompson’s 2006 study of 448 children with meningococcal disease, the signs everyone watches for (rash, stiff neck, confusion) showed up at a median of 13 to 22 hours. The early ones (leg pain, cold hands and feet, off-color skin) showed up around 8 hours.⁶ What families watch for is what comes last. Know the glass test anyway, because parents ask: press a clear glass on the rash, and spots that don’t fade (petechiae and purpura) are the worrying kind. Bad thing to wait for, and harder to see on darker skin.

So instead of focusing on the symptom list when you counsel focus on the slope. A young adult who looks worse than the illness should make them look, and is worse hour to hour instead of day to day, is the one to send in.

If someone was actually exposed

Close contacts need prophylaxis fast, ideally within 24 hours. Who counts is decided by public health, not by proximity or by how worried someone is. That makes the list short to household members, roommates, and anyone directly exposed to oral secretions in the week before symptoms started. Something like a shared lecture hall or an interaction at a cash register doesn’t qualify.

Ciprofloxacin is also no longer the automatic choice. Resistant strains have been climbing since 2019, and CDC now tells health departments to prefer rifampin, ceftriaxone, or azithromycin in areas crossing two thresholds in a rolling year: two or more invasive cases caused by resistant strains, and 20% or more of cases resistant.⁷ New York went further in August 2024 and told providers to stop using cipro for this outright.⁸

Where preparation actually helps here

Most of what we do at Jase runs on a simple premise: for a short list of common, well-understood conditions, the clinical work can happen before the patient needs it, so nobody is sorting it out alone at 11pm. That’s what we mean by appropriate medical preparation.

Meningitis is where that premise stops. There’s no kit for this one. The preparation that helps a college student is a complete vaccination record and a low threshold for the ER when worrying symptoms appear.And nobody should be dosing themselves out of a standby antibiotic supply after a campus scare, a Jase kit included. That skips the resistance picture that decides the right drug, and it skips the contact tracing that decides whether they need anything at all.

We’re here for the times when primary care isn’t there, and this isn’t one of them. We’ll keep publishing where we draw these lines.

The bottom line

MenACWY is routine at 11 to 12 with a booster at 16, and it’s what the college form is asking about. MenB is a separate two-dose series under shared clinical decision-making, unless your patient is one of the people who gets it routinely. Brands don’t mix, so get the product name before dose two. And a shot record doesn’t rule meningitis out. When the slope is hours instead of days, that’s the ER.


Sources

  1. CDC. Meningococcal vaccine recommendations for healthcare providers. https://www.cdc.gov/meningococcal/hcp/vaccine-recommendations/index.html
  2. Mbaeyi SA, Bozio CH, Duffy J, et al. Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020. MMWR Recomm Rep. 2020;69(RR-9):1-41. https://www.cdc.gov/mmwr/volumes/69/rr/rr6909a1.htm
  3. Marshall GS, Dempsey AF, Srivastava A, Isturiz RE. US College Students Are at Increased Risk for Serogroup B Meningococcal Disease. J Pediatric Infect Dis Soc. 2019;9(2):244-247. https://pmc.ncbi.nlm.nih.gov/articles/PMC7192401/
  4. CDC. Use of the GSK MenACWY-CRM/MenB-4C Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2025. MMWR. 2026;75(1). https://www.cdc.gov/mmwr/volumes/75/wr/mm7501a2.htm
  5. CDC. About Viral Meningitis. https://www.cdc.gov/meningitis/about/viral-meningitis.html
  6. Thompson MJ, Ninis N, Perera R, et al. Clinical recognition of meningococcal disease in children and adolescents. Lancet. 2006;367(9508):397-403. https://pubmed.ncbi.nlm.nih.gov/16458763/
  7. Berry I, Rubis AB, Howie RL, et al. Selection of Antibiotics as Prophylaxis for Close Contacts of Patients with Meningococcal Disease in Areas with Ciprofloxacin Resistance, United States, 2024. MMWR Morb Mortal Wkly Rep. 2024;73(5):99-103. https://www.cdc.gov/mmwr/volumes/73/wr/mm7305a2.htm
  8. New York State Department of Health. State directs providers to discontinue use of ciprofloxacin to prevent meningococcal disease due to increasing antimicrobial resistance. August 14, 2024. https://www.health.ny.gov/press/releases/2024/2024-08-14_ciprofloxacin.htm

 

Lifesaving Solutions

Everyone should be empowered to care for themselves and their loved ones during the unexpected. Check out our recent lifesaving products today.

Recent Posts

Keeping you informed and safe.

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can’t Be Missed

For Clinicians | Which Medications Can't Be Missed How to Help Patients Rank their Medication List Before a Disruption By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C September is National...

read more
For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis

For Clinicians | Purulent vs. Nonpurulent Cellulitis What an Antibiotic Can't Do for a Wound By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Most of what goes wrong with a wound isn't fixed by...

read more
For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water

For Clinicians | Medication Exposed to Flood Water The FDA Rule and Its One Exception By Dr. Jamie Wilkey, PharmD — Director of Clinical Strategy, JaseMedically reviewed and edited by Kristen Carpenter, PA-C Today we are covering three things: what FDA actually...

read more

Join Our Newsletter

Our mission is to help you be more medically prepared. Join our newsletter and follow us on social media for health and safety tips each week!